Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xuping Xie and Kumari Lokugamage.
Xuping Xie
Connection Strength
1.090
Kumari Lokugamage
  1. Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2021 Jun 21; 12(1):3984.
    View in: PubMed
    Score: 0.238
  2. Engineering SARS-CoV-2 using a reverse genetic system. Nat Protoc. 2021 03; 16(3):1761-1784.
    View in: PubMed
    Score: 0.232
  3. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
    View in: PubMed
    Score: 0.227
  4. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020 05 13; 27(5):841-848.e3.
    View in: PubMed
    Score: 0.219
  5. Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 Jul; 595(7865):E1.
    View in: PubMed
    Score: 0.060
  6. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.058
  7. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.